2011
DOI: 10.1093/ndt/gfr211
|View full text |Cite
|
Sign up to set email alerts
|

Protective effect of N-acetylcysteine from drug-induced ototoxicity in uraemic patients with CAPD peritonitis

Abstract: The present study suggests that intraperitoneal aminoglycoside and vancomycin administration in CAPD patients may cause low- and high-frequency hearing loss, and this ototoxic effect is related to the dose given. It was found that when the antioxidant NAC is administered alone, it prevents ototoxicity, associated with intraperitoneal amikacin and vancomycin in patients with CAPD peritonitis. In addition, it was revealed that NAC may also have a curative effect on impaired high-frequency hearing functions.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

2
31
1
2

Year Published

2012
2012
2022
2022

Publication Types

Select...
6
3

Relationship

0
9

Authors

Journals

citations
Cited by 45 publications
(36 citation statements)
references
References 29 publications
2
31
1
2
Order By: Relevance
“…NAC blocked gentamicin, histopathologically and audiologically antagonizing its ototoxic effect. This was concordant with what we have found in our previous clinical study [16] , in which NAC antagonized the ototoxic effect (of a different aminoglicoside) without interfering with the antibiotic effect.…”
Section: Discussionsupporting
confidence: 93%
See 1 more Smart Citation
“…NAC blocked gentamicin, histopathologically and audiologically antagonizing its ototoxic effect. This was concordant with what we have found in our previous clinical study [16] , in which NAC antagonized the ototoxic effect (of a different aminoglicoside) without interfering with the antibiotic effect.…”
Section: Discussionsupporting
confidence: 93%
“…Intraperitoneal aminoglycoside had caused a low and high frequency dose-related hearing loss. In that study, N-acetylcysteine (NAC) had prevented ototoxicity and had a curative effect on hearing loss at high-frequencies [16] .…”
Section: Introductionmentioning
confidence: 98%
“…NAC is well known drug of choice for emergency treatment of APAP poisoning and related toxicity (Tokgoz et al, 2011). NAC allows the generation of sufficient level of glutathione to react with toxic intermediates NAPQI and prevent hepatic necrosis.…”
Section: Discussionmentioning
confidence: 99%
“…Two of these trials were open-label,14 16 and one was a randomised, placebo-controlled trial 17. Patients received 600 mg NAC twice daily for the duration of aminoglycoside treatment,16 for a total of 14 days17 or for up to 7 days14 after completion of aminoglycoside treatment. The aminoglycosides used were amikacin (n=2) and gentamicin (n=1).…”
Section: Resultsmentioning
confidence: 99%